BioCentury | Aug 3, 2009
Strategy

What might fit

...inhibitor (PPI) Secondary prevention of cardiovascular events Start Ph III in2H09 Bial-Portela & Ca. S.A. BIA 5-453...
BioCentury | Mar 9, 2009
Strategy

Tying down Europe

...II testing: BIA 9-1067 , a catechol-O-methyl-transferase (COMT) inhibitor to treat Parkinson's disease (PD); and BIA 5-453...
Items per page:
1 - 2 of 2